Compositions of quaternary ammonium containing bioavailability enhancers

Details for Australian Patent Application No. 2004289222 (hide)

Owner Shire Laboratories, Inc.

Inventors Kidane, Argaw

Agent Spruson & Ferguson

Pub. Number AU-B-2004289222

PCT Pub. Number WO2005/046663

Priority 60/517,196 04.11.03 US

Filing date 4 November 2004

Wipo publication date 26 May 2005

Acceptance publication date 21 January 2010

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

A61K 31/14 (2006.01) - Quaternary ammonium compounds, e.g. edrophonium, choline

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Event Publications

6 April 2006 PCT application entered the National Phase

  PCT publication WO2005/046663 Priority application(s): WO2005/046663

21 January 2010 Application Accepted

  Published as AU-B-2004289222

20 May 2010 Standard Patent Sealed

10 June 2010 Assignment Registered

  Shire Laboratories, Inc. The patent has been assigned to Supernus Pharmaceuticals, Inc. Mortgages Registered - Section 187, Reg. 19 (The name in the parentheses is that of the mortgagee)

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004289223-Once daily dosage forms of trospium

2004289221-Sustained release of positively charged pharmacologically active molecules from a matrix containing polymers with polarized oxygen atoms